SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
15 references·16 citing·28 second hop
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012)Reporting Recommendations for Tumor Marke…CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updat…CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updat…CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Explanation and …The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA Statement for Repo…Why Most Discovered True Associations Are Inflated (2008)Why Most Discovered True Asso…Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (2008)Systematic Review of the Empi…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The Strengthening the Reporti…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies (2007)The Strengthening the Reporti…Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Strengthening the Reporting o…Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Strengthening the Reporting o…REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005)REporting recommendations for…Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) (2005)Reporting Recommendations for…The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The Revised CONSORT Statement…The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)The CONSORT Statement: Revise…International Committee of Medical Journal Editors. (1990)International Committee of Me…Structured reporting to improve transparency of analyses in prognostic marker studies (2022)Structured reporting to impro…REMARK guidelines for tumour biomarker study reporting: a remarkable history (2022)REMARK guidelines for tumour …A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration (2021)A CHecklist for statistical A…TRIPOD statement: a preliminary pre-post analysis of reporting and methods of prediction models (2020)TRIPOD statement: a prelimina…A guide to systematic review and meta-analysis of prognostic factor studies (2019)A guide to systematic review …Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration (2018)Reporting Recommendations for…Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018)Overinterpretation and misrep…Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles (2017)Did the reporting of prognost…Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement (2015)Transparent Reporting of a mu…Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement (2015)Transparent Reporting of a Mu…Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement (2015)Transparent Reporting of a Mu…Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) (2015)Transparent Reporting of a Mu…Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis ( TRIPOD ): the TRIPOD statement (2015)Transparent Reporting of a Mu…Better Reporting of Scientific Studies: Why It Matters (2013)Better Reporting of Scientifi…Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting (2012)Publication of Tumor Marker R…A catalogue of reporting guidelines for health research (2009)A catalogue of reporting guid…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010)SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014)Standards for Reporting Qualitative Research (2014)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Empirical Evidence of Bias (1995)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative (2003)Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups (2007)Assessing the quality of controlled clinical trials (2001)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Fundamental Movement Skills in Children and Adolescents (2010)The Role of Behavioral Science Theory in Development and Implementation of Public Health Interventions (2010)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Measuring inconsistency in meta-analyses (2003)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration (2015)Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration (2008)Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement (2015)
this work references cited by second hop

References

  • 2009The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration28,094 cited
  • 2007The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies22,917 cited
  • 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials13,365 cited
  • 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials9,314 cited
  • 2010CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials8,873 cited
  • 2007Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration8,588 cited
  • 2001The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration3,828 cited
  • 2007Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration3,542 cited
  • 2007The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies2,698 cited
  • 2001The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials2,545 cited
  • 2005Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)2,148 cited
  • 2008Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias1,544 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2008Why Most Discovered True Associations Are Inflated1,489 cited
  • 2005REporting recommendations for tumour MARKer prognostic studies (REMARK)1,391 cited
  • 1990International Committee of Medical Journal Editors.415 cited
  • Cited by

    • 2009A catalogue of reporting guidelines for health research1,047 cited
    • 2015Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement885 cited
    • 2015Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD)791 cited
    • 2019A guide to systematic review and meta-analysis of prognostic factor studies753 cited
    • 2018Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration488 cited
    • 2015Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement439 cited
    • 2015Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement328 cited
    • 2021A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration266 cited
    • 2012Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting185 cited
    • 2015Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis ( TRIPOD ): the TRIPOD statement137 cited
    • 2020TRIPOD statement: a preliminary pre-post analysis of reporting and methods of prediction models90 cited
    • 2017Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles39 cited
    • 2018Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review36 cited
    • 2022Structured reporting to improve transparency of analyses in prognostic marker studies27 cited
    • 2013Better Reporting of Scientific Studies: Why It Matters26 cited
    • 2022REMARK guidelines for tumour biomarker study reporting: a remarkable history21 cited